Bloustein School to host panel discussion on significance, implications of

New Jersey Aid in Dying Act for healthcare providers, administrators, October 30

WHAT: A panel discussion, “Implications of the New Jersey Aid in Dying Act for Healthcare Providers and Administrators”

WHO: Moderator: Hon. Paul W. Armstrong, JSC (ret). M.A., J.D., LL.M., Senior Policy Fellow, Edward J. Bloustein School of Planning and Public Policy, Rutgers University. Panelists: Hon. Christopher (Kip) Bateman (R 16), New Jersey State Senate, Senate Sponsor for Legislation; Hon. Cathy D. Bennett, J.D., President & CEO, New Jersey Hospital Association; Joseph Fennelly, MD, Chair Emeritus, Bioethics Committee of the Medical Society of New Jersey; T. Patrick Hill, B.D., M.A., Ph.D., Associate Teaching Professor, Ethics, Edward J. Bloustein School of Planning and Public Policy; (invited) Hon. Judith M. Persichilli *, R.N., B.S.N., M.A., Commissioner, New Jersey Department of Health

WHEN: 5:00-6:30 p.m., Wednesday, October 30, 2019

WHERE:  Governor James J. Florio Special Events Forum, Edward J. Bloustein School of Planning and Public Policy, 33 Livingston Avenue, New Brunswick, NJ

BACKGROUND: New Jersey joins seven other states in promulgating an Aid in Dying for the Terminally Ill statute, sponsored by Senator Kip Bateman (R16) and Assemblyman John Burzichelli (D3), signed into law by Governor Phil Murphy and enacted on August 1, 2019. The law allows terminally ill New Jersey adults who are within 6 months of dying to end their lives peacefully, with dignity, and at their own discretion.

In light of its societal significance for New Jersey, the Bloustein School, with assistance from MDAdvantage, the Rutgers Graduate Society of Healthcare Leaders and the Future Healthcare Administrators of Rutgers, is convening a distinguished panel of our state’s healthcare leaders to participate in an open dialogue about the implications this law may have for physicians, nurses, pharmacists, healthcare administrators, related healthcare professionals and society at large.

Hon. Paul Armstrong will moderate the panel. Panelists will discuss the legislation and implications for members of the healthcare community. A Q&A period will follow; if you wish to have specific questions asked during the panel, please fill out our form here.